Aktis Oncology, Inc. Common stock AKTS
$24.93
+4.79%
at last close
Analyst Consensus
- Consensus Rating
- Buy (5 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $34.75
- Implied Upside
- +39.4%
- Price Target Range
- $31.00 – $40.00
- Analysts (12 mo)
- 5
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-14 | JP MorganJessica Fye |
Maintains | Overweight | $30 → $33 |
| 2026-06-16 | Raymond JamesChristopher Raymond |
Initiates coverage on | Strong buy | $40 |
| 2026-06-02 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $33 → $35 |
| 2026-04-29 | William BlairAlexandra Ramsey |
Initiates coverage on | Outperform | — |
| 2026-03-31 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $30 → $33 |
| 2026-03-09 | HC Wainwright & Co.Robert Burns |
Initiates coverage on | Buy | $30 |
| 2026-02-03 | Leerink Partners |
Initiates coverage on | Outperform | $31 |
| 2026-02-03 | JP MorganJessica Fye |
Initiates coverage on | Overweight | $30 |
| 2024-01-04 | Piper SandlerHarsh Kumar |
Downgrades | Overweight → Neutral | $2 → $1 |
| 2023-09-07 | OppenheimerRick Schafer |
Maintains | Outperform | $6 → $3 |
| 2023-09-07 | B. Riley SecuritiesCraig Ellis |
Downgrades | Buy → Neutral | $9 → $2 |
| 2023-05-09 | OppenheimerRick Schafer |
Maintains | Outperform | $7 → $6 |
| 2023-05-09 | Roth MKMSuji Desilva |
Maintains | Buy | $10 → $5 |
| 2023-01-24 | B. Riley SecuritiesCraig Ellis |
Initiates coverage on | Buy | $9 |
| 2022-11-15 | OppenheimerRick Schafer |
Maintains | Outperform | $8 → $7 |
| 2022-09-13 | Piper SandlerHarsh Kumar |
Maintains | Overweight | $7 → $5 |
| 2022-05-03 | Piper SandlerHarsh Kumar |
Maintains | Overweight | $11 → $7 |
| 2021-11-02 | OppenheimerRick Schafer |
Maintains | Outperform | $18 → $13 |
| 2021-05-04 | Roth CapitalSujeeva De Silva |
Maintains | Buy | $25 → $16 |
| 2021-01-04 | Roth CapitalSujeeva De Silva |
Maintains | Buy | $12 → $16 |
| 2019-12-20 | Northland Capital MarketsGus Richard |
Maintains | Market perform | $7 → $7 |
| 2019-09-18 | Northland Capital MarketsGus Richard |
Downgrades | Outperform → Market perform | — |
| 2019-07-10 | Northland Capital MarketsGus Richard |
Upgrades | Market perform → Outperform | — |
| 2019-02-05 | Northland Capital MarketsGus Richard |
Downgrades | Outperform → Market perform | — |
| 2018-08-30 | OppenheimerRick Schafer |
Initiates coverage on | Outperform | $10 |
| 2018-06-22 | Loop Capital |
Initiates coverage on | Buy | $15 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $24.93
- Market Cap
- $1.33 billion
- 52-Week Range
- $14.72 – $34.19
- Average Volume
- 347K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.